MedTrace Logo

Optimizing the Tobacco Cessation Clinical Decision Support Tool.

NCT03714191 · Status: COMPLETED · Type: OBSERVATIONAL · Enrollment: 54417

Last updated 2021-07-21

No results posted yet for this study

Summary

The existing tobacco cessation best practice advisory (BPA) fires for providers (physicians, residents, fellows, midwives, nurse practitioners, physician assistants) during outpatient encounters when a patient is identified as a current tobacco user in the Social History section of their chart. The BPA was designed to help facilitate tobacco cessation interventions; it is part of the The Centers for Medicare \& Medicaid Services (CMS) Quality Payment Program (QPP). The purpose of the project is to optimize this BPA utilization and improve patient outcomes by comparing multiple versions of the tobacco cessation BPA.

Conditions

  • Tobacco Use Cessation

Interventions

OTHER

Patient Outcomes

The intervention includes different versions of the BPA design and message.

OTHER

Billing documentation

The intervention includes different versions of the BPA design and message.

OTHER

Regulatory

The intervention includes different versions of the BPA design and message.

Sponsors & Collaborators

Eligibility

Min Age
12 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2018-10-03
Primary Completion
2019-05-24
Completion
2020-02-29

Countries

  • United States

Study Locations

More Related Trials

Entities

Companies

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT03714191 on ClinicalTrials.gov